Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Fricker

Showing results (191-200 of 193) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 193 results.
Journal of Medicinal Chemistry|December 20, 2017
Identification of [<sup>18</sup>F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET ImagingVadim Bernard-Gauthier, Andrew V Mossine, Anne Mahringer, et al.
Journal of Medicinal Chemistry|July 12, 2017
A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-HumanVadim Bernard-Gauthier, Justin J Bailey, Andrew V Mossine, et al.
Science Translational Medicine|April 12, 2023
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathyTony S Eteläinen, M Catarina Silva, Johanna K Uhari-Väänänen, et al.
Pageof 20

Showing results (191-200 of 193) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 193 results.
Journal of Medicinal Chemistry|December 20, 2017
Identification of [<sup>18</sup>F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET ImagingVadim Bernard-Gauthier, Andrew V Mossine, Anne Mahringer, et al.
Journal of Medicinal Chemistry|July 12, 2017
A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-HumanVadim Bernard-Gauthier, Justin J Bailey, Andrew V Mossine, et al.
Science Translational Medicine|April 12, 2023
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathyTony S Eteläinen, M Catarina Silva, Johanna K Uhari-Väänänen, et al.
Pageof 20